We now further delineate the clinical and mutational spectrum of a FBXO11-associated NDD by adding 23 additional cases with de novo FBXO11 variants identified through either chromosomal microarray testing or exome sequencing. The gene discussed is FBXO11; the disease is Neurodevelopmental delay.